Literature DB >> 25083218

Aspirin hypersensitivity and desensitization protocols: implications for cardiac patients.

Phil Lambrakis1, Gordon F Rushworth2, Jane Adamson1, Stephen J Leslie3.   

Abstract

Aspirin or acetylsalicylic acid is an important therapy for many cardiology patients but hypersensitivity to this drug affects around 1% of the population and intolerance may affect up to 20%. While alternative medications to aspirin are available, in many cases there is a compelling need for aspirin therapy. In these patients, aspirin desensitization may be considered. However, this is a complex issue with a lack of international standardization. This article reviews the available evidence for aspirin desensitization and provides practical advice for the management of these patients.

Entities:  

Keywords:  acetylsalicylic acid; allergy; aspirin; desensitization; hypersensitivity

Year:  2011        PMID: 25083218      PMCID: PMC4110834          DOI: 10.1177/2042098611422558

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  25 in total

Review 1.  Aspirin sensitivity: implications for patients with coronary artery disease.

Authors:  Raghava R Gollapudi; Paul S Teirstein; Donald D Stevenson; Ronald A Simon
Journal:  JAMA       Date:  2004-12-22       Impact factor: 56.272

2.  Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients.

Authors:  O P Schaefer; J M Gore
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

Review 3.  Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.

Authors:  Oliver Pfaar; Ludger Klimek
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-06

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.

Authors:  Stéphane Silberman; Catherine Neukirch-Stoop; Philippe Gabriel Steg
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

Review 6.  Desensitization for drug allergy.

Authors:  Mariana Castells
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-12

7.  An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.

Authors:  Marcus Shaker; Ano Lobb; Pamela Jenkins; Daniel O'Rourke; Steve K Takemoto; Salil Sheth; Thomas Burroughs; Mark S Dykewicz
Journal:  J Allergy Clin Immunol       Date:  2007-08-22       Impact factor: 10.793

8.  The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients.

Authors:  H Vally; M L Taylor; P J Thompson
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 9.  Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers.

Authors:  D M Lang
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more
  3 in total

1.  Patient characterization and predictors of aspirin desensitization response.

Authors:  Zuhui Cheong; Cheryl Ying Lin Tan; Chuan Poh Lim; Jie Lin Soong; Chiara Jia Min Chong; Adrian Kwok Wai Chan
Journal:  Asia Pac Allergy       Date:  2021-04-27

Review 2.  Aspirin Intolerance: Experimental Models for Bed-to-Bench.

Authors:  Masamichi Yamashita
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 3.  Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management.

Authors:  Ravi A Thakker; Leonardo Salazar; Deaa Abu Jazar; Pooja Bhakta; Bryan Baker; Chandani Patel; Ayman Elbadawi; Mayank Agarwal; Aiham Albaeni; Mohammed Saleh; Jonathan Esclovan; Danielle El Haddad; Hashim Alwash; Ankur Kalra; Sachin S Goel; Robert Jay Widmer; Khaled Chatila; Wissam Khalife; Afaq Motiwala; Jennifer McCracken; Hani Jneid; Syed Gilani
Journal:  Cardiol Ther       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.